GRX (Gabelli Healthcare & WellnessRx Trust) Beneish M-Score: 4.08 (As of Jul. 25, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GRX Gabelli Healthcare & WellnessRx Trust GRX
33 GF Score
Price $9.56
! 3 Warning Signs
View Full Analysis

What is Gabelli Healthcare & WellnessRx Trust Beneish M-Score?

Gabelli Healthcare & WellnessRx Trust GRX +0.95% 33 Beneish M-Score is 4.08 as of Jul. 25, 2026, which is at its 10-year median of 4.08. GuruFocus rates GRX with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 952 Asset Management companies, Gabelli Healthcare & WellnessRx Trust ranks worse than 92.75% on this metric.

Note: Financial institutions were excluded from the sample in Beneish paper when calculating Beneish M-Score. Thus, the prediction might not fit banks and insurance companies.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 4.08 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Gabelli Healthcare & WellnessRx Trust's Beneish M-Score or its related term are showing as below:

GRX' s Beneish M-Score Range Over the Past 10 Years
Min: 4.08   Med: 4.08   Max: 4.08
Current: 4.08

During the past 9 years, the highest Beneish M-Score of Gabelli Healthcare & WellnessRx Trust was 4.08. The lowest was 4.08. And the median was 4.08.

GRX
33GF Score
Gabelli Healthcare & WellnessRx Trust GRX
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gabelli Healthcare & WellnessRx Trust Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Gabelli Healthcare & WellnessRx Trust for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.1072+0.528 * 1+0.404 * 1+0.892 * 8.6501+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.1316+4.679 * 0.018145-0.327 * 0
=4.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was $0.39 Mil.
Revenue was $2.97 Mil.
Gross Profit was $2.97 Mil.
Total Current Assets was $0.00 Mil.
Total Assets was $241.89 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.00 Mil.
Selling, General, & Admin. Expense(SGA) was $0.48 Mil.
Total Current Liabilities was $0.00 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was $2.30 Mil.
Gross Profit was $0.00 Mil.
Cash Flow from Operations was $-2.09 Mil.
 Total Receivables was $0.42 Mil.
Revenue was $0.34 Mil.
Gross Profit was $0.34 Mil.
Total Current Assets was $0.00 Mil.
Total Assets was $225.71 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.00 Mil.
Selling, General, & Admin. Expense(SGA) was $0.42 Mil.
Total Current Liabilities was $0.00 Mil.
Long-Term Debt & Capital Lease Obligation was $0.01 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.393 / 2.967) / (0.424 / 0.343)
=0.132457 / 1.236152
=0.1072

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.343 / 0.343) / (2.967 / 2.967)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0 + 0) / 241.889) / (1 - (0 + 0) / 225.714)
=1 / 1
=1

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2.967 / 0.343
=8.6501

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 0)) / (0 / (0 + 0))
= /
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0.478 / 2.967) / (0.42 / 0.343)
=0.161105 / 1.22449
=0.1316

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 0) / 241.889) / ((0.01 + 0) / 225.714)
=0 / 4.4E-5
=0

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2.295 - 0 - -2.094) / 241.889
=0.018145

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Gabelli Healthcare & WellnessRx Trust has a M-score of 4.08 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 4.08 mean?
Gabelli Healthcare & WellnessRx Trust (GRX) has a Beneish M-Score of 4.08 as of Jul. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Gabelli Healthcare & WellnessRx Trust and its competitors. This is near median its historical median of 4.08. Over the past decade, Gabelli Healthcare & WellnessRx Trust's Beneish M-Score has ranged from 4.08 to 4.08. According to the industry distribution chart, Gabelli Healthcare & WellnessRx Trust ranks #883 out of 952 companies in the Asset Management industry, placing it in the top 92.8%.
Is Gabelli Healthcare & WellnessRx Trust's Beneish M-Score too high?
Gabelli Healthcare & WellnessRx Trust's current Beneish M-Score of 4.08 is near median its 10-year median of 4.08. Over the past 10 years, this metric has ranged from a low of 4.08 to a high of 4.08. Based on the distribution chart, Gabelli Healthcare & WellnessRx Trust ranks #883 out of 952 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, Gabelli Healthcare & WellnessRx Trust has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Gabelli Healthcare & WellnessRx Trust's Beneish M-Score compare to BGX and IHD?
According to the Asset Management industry distribution chart, Gabelli Healthcare & WellnessRx Trust ranks #883 out of 952 companies for Beneish M-Score. This places Gabelli Healthcare & WellnessRx Trust in the lower half of its industry. Historically, Gabelli Healthcare & WellnessRx Trust's own Beneish M-Score has ranged from 4.08 to 4.08 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for an Asset Management company?
A good Beneish M-Score depends on the Asset Management industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Gabelli Healthcare & WellnessRx Trust and its competitors. Gabelli Healthcare & WellnessRx Trust's current Beneish M-Score is 4.08, which is near median its own 10-year median of 4.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gabelli Healthcare & WellnessRx Trust stock overvalued right now?
Gabelli Healthcare & WellnessRx Trust (GRX) has a current Beneish M-Score of 4.08. The current Beneish M-Score is 4.08, which is near median its 10-year median of 4.08. Gabelli Healthcare & WellnessRx Trust's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Gabelli Healthcare & WellnessRx Trust (GRX), the current Beneish M-Score is 4.08 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gabelli Healthcare & WellnessRx Trust Business Description

Address One Corporate Center, Rye, NY, USA, 10580-1422
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
33GF Score

Get the complete analysis for GRX

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.56
Price